New Zealand markets open in 13 minutes

Genmab A/S (GMAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
45.66-0.75 (-1.62%)
At close: 4:00PM EDT
46.00 +0.34 (+0.74%)
After hours: 04:28PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
7,321,000
10,111,000
5,366,000
3,025,137
2,365,436
Operating expenses
Research development
3,416,000
3,137,000
2,386,000
1,431,159
874,278
Selling general and administrative
841,000
661,000
342,000
213,695
146,987
Total operating expenses
4,257,000
3,798,000
2,728,000
1,644,854
1,021,265
Operating income or loss
3,064,000
6,313,000
2,638,000
1,380,283
1,344,171
Interest expense
12,000
10,000
14,000
417
2,802
Total other income/expenses net
-212,000
-583,000
108,000
169,183
-319,075
Income before tax
3,068,000
5,904,000
2,859,000
1,611,971
1,063,720
Income tax expense
555,000
1,146,000
693,000
139,830
-39,831
Income from continuing operations
2,513,000
4,758,000
2,166,000
1,472,141
1,103,551
Net income
2,513,000
4,758,000
2,166,000
1,472,141
1,103,551
Net income available to common shareholders
2,513,000
4,758,000
2,166,000
1,472,141
1,103,551
Basic EPS
-
7.30
3.44
2.40
1.81
Diluted EPS
-
7.22
3.40
2.37
1.78
Basic average shares
-
651,790
629,628
612,680
608,340
Diluted average shares
-
658,859
636,368
620,450
620,940
EBITDA
-
6,173,000
3,012,000
1,699,985
1,136,273